Skip to content
Glenn Kenworthy

Glenn Kenworthy

Social Entrepreneur | Marketer | Investor | Business Consultancy

  • Home
  • About
  • Causes
  • GKMC Consultancy
  • Non-Executive Director
  • MedTechBlogs
  • Get in touch
Posted on June 19, 2018 by Glenn Kenworthy

The 3rd LVAD to be successful in preclinicals with CET Technology. #LVAD #HybridFILVAS #CET

http://trendlines.com/leviticus-cardio-successful-preclinical-demonstrates-wireless-power-to-jarvik-2000/

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email
Like Loading...

Related

Leave a comment Cancel reply

Post navigation

Previous PostPrevious Leviticus Cardio confirms the successful completion of multiple long term chronic animal study.
Create a website or blog at WordPress.com
  • Comment
  • Reblog
  • Subscribe Subscribed
    • Glenn Kenworthy
    • Already have a WordPress.com account? Log in now.
    • Glenn Kenworthy
    • Subscribe Subscribed
    • Sign up
    • Log in
    • Copy shortlink
    • Report this content
    • View post in Reader
    • Manage subscriptions
    • Collapse this bar
%d